期刊文献+

肺炎衣原体0308基因真核表达载体构建及表达检测

Construction of eukaryotic expression vector for Cpn0308 gene and its expression in eukaryotic cells
下载PDF
导出
摘要 目的构建肺炎衣原体AR39株Cpn0308基因真核表达重组质粒,体外转染HeLa细胞并检测表达情况,为Cpn核酸疫苗的研制做准备。方法应用PCR技术从CpnAR39株基因组中扩增Cpn0308全长基因,重组入pcDNA3.1/HisA真核表达载体相应位点,进行酶切鉴定和序列分析后,运用脂质体介导重组质粒转染HeLa细胞,间接免疫荧光技术检测目的蛋白在真核细胞中表达情况。结果 PCR扩增得到393bp的特异性Cpn0308基因,筛选鉴定出pcDNA3.1/HisA-Cpn0308真核表达重组体,序列测定证实与GeneBank登录的CpnAR39株Cpn0308基因一致;间接免疫荧光法检测到重组质粒转染的HeLa细胞能够表达目的蛋白。结论成功构建pcDNA3.1/HisA-Cpn0308真核表达重组体,且该重组体能够在体外真核细胞中表达目的蛋白,为进一步研究CpnDNA疫苗以及研究该蛋白的生物学功能提供实验基础。 Objective To construct the recombinant plasmid containing Cpn0308 gene from Chlamydia pneumoniae AR39,and transfect it into HeLa cells to express the protein,in preparation for the development of DNA vaccine.Methods Cpn0308 gene was amplified from the genomic DNA of CpnAR39 by polymerase chain reaction(PCR),the gene was inserted into appropriate site of pcDNA3.1/His A vector.After identification by restrictive enzymes digestion and sequencing,the recombinant plasmid was transfected into HeLa cells using Liposome.The expressed protein was identified by indirect immunofluorescence assay.Results The 393bp specific gene Cpn0308 was obtained,The DNA sequence of Cpn0308 gene was consistent with the nucleotide sequence that had been published on Genebank.Indirect immunofluorescence assay showed that Cpn0308 protein expressed in HeLa cells.Conclusion Successfully constructed the eukaryotic expression recombinant pcDNA3.1/His A-Cpn0308,and the recombinant plasmid can express Cpn0308 protein in eukaryotic system which lay the foundation for studying the biological activities and the development of the chlamydia pneumoniae vaccine.
出处 《北京医学》 CAS 2010年第12期975-978,共4页 Beijing Medical Journal
基金 河北省科技厅资助项目(项目编号07276934)
关键词 肺炎衣原体 真核表达 间接免疫荧光技术 DNA疫苗 Chlamydia pneumoniae Eukaryotic expression Indirect immunofluorescence assay DNA vaccine
  • 相关文献

参考文献13

  • 1Burillo A,Bouza E. Chlamydophila pneumoniae. Infect Dis Clin North Am,2010,24:61-71.
  • 2Campbell LA, Yaraei K, Van Lenten B, et al. The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis. Micro Bes Infect,2010,12:598 -606.
  • 3Chaturvedi AK, Gaydos CA, Agreda P, et al. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev,2010,19:1498-1505.
  • 4Atik B, Johnston SC, Dean D. Association of carotid plaque Lp-PLA (2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke. PLoS One,2010,5: e11026.
  • 5Rollins DR, Beuther DA, Martin RJ. Update on infection and antibiotics in asthma. Curr Allergy Asthma Rep,2010,10:67-73.
  • 6Gerard HC, Whittum HJA, Carter JD, et al. The pathogenic role of Chlamydia in spondyloarthritis. Cart Opin Rheumatol,2010,22: 363-367.
  • 7Petyaev IM, Zigangirova NA, Petyaev AM, et al. Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome. Int J Med Sci,2010,7:181-190.
  • 8Hilden J, Lind I, Kolmos H J, et al. Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the claricor trial. Diagn Microbiol Infect Dis,2010,66:385-392.
  • 9Wiwanitkit V. Chlamydia pneumoniae and metabohc syndrome. South Med J,2010,103:715.
  • 10Gerard HC, Whittum-Hudson JA, Carter JD, et al. The pathogenic role of Chlamydia in spondyloarthritis. Curr Opin Rheumatol,2010,22:363-367.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部